Certara Research Development Over Time
| CERT Stock | USD 7.03 0.00 0.00% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Certara Performance and Certara Correlation. Is there potential for Health Care Technology market expansion? Will Certara introduce new products? Factors like these will boost the valuation of Certara. Projected growth potential of Certara fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Certara listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Earnings Share 0.07 | Revenue Per Share | Quarterly Revenue Growth 0.103 | Return On Assets |
Understanding Certara requires distinguishing between market price and book value, where the latter reflects Certara's accounting equity. The concept of intrinsic value - what Certara's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Certara's price substantially above or below its fundamental value.
It's important to distinguish between Certara's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Certara should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Certara's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Research Development Analysis
Compare Certara and related stocks such as 10X Genomics, Clover Health Investments, and Vericel Corp Ord Research Development Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TXG | 32.2 M | 32.2 M | 32.2 M | 32.2 M | 32.2 M | 32.2 M | 32.2 M | 32.2 M | 47.5 M | 83.1 M | 123.4 M | 211.8 M | 265.7 M | 270.3 M | 264.7 M | 304.4 M | 178.6 M |
| VCEL | 13.4 M | 21.3 M | 26 M | 15.1 M | 21.3 M | 18.9 M | 15.3 M | 12.9 M | 13.6 M | 30.4 M | 13 M | 16.3 M | 19.9 M | 21 M | 24.8 M | 28.5 M | 15.9 M |
| SDGR | 27.7 M | 27.7 M | 27.7 M | 27.7 M | 27.7 M | 27.7 M | 27.7 M | 27.7 M | 34.5 M | 39.4 M | 64.7 M | 90.9 M | 126.4 M | 181.8 M | 201.8 M | 232.1 M | 243.7 M |
| NHC | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.09 | 0.05 | 0.15 | 0.03 | 0.08 | 0.08 | 0.092 | 0.0966 |
| OMCL | 11.3 M | 22 M | 23.7 M | 29.1 M | 27.8 M | 35.2 M | 57.8 M | 66 M | 64.8 M | 68.6 M | 70.2 M | 75.7 M | 105 M | 97.1 M | 90.4 M | 88.7 M | 45.1 M |
| QDEL | 4.1 M | 26.3 M | 27.7 M | 34.2 M | 37.9 M | 35.5 M | 38.7 M | 33.6 M | 51.6 M | 52.6 M | 84.3 M | 95.7 M | 187.9 M | 246.8 M | 218.7 M | 251.5 M | 264.1 M |
| TWST | 18.2 M | 18.2 M | 18.2 M | 18.2 M | 18.2 M | 18.2 M | 19.2 M | 20.3 M | 35.7 M | 43 M | 69.1 M | 120.3 M | 106.9 M | 90.9 M | 80.3 M | 92.3 M | 66.4 M |
Certara and related stocks such as 10X Genomics, Clover Health Investments, and Vericel Corp Ord Research Development description
My Equities
My Current Equities and Potential Positions
| Certara | CERT |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 4 Radnor Corporate |
| Exchange | NASDAQ Exchange |
USD 7.03
Additional Tools for Certara Stock Analysis
When running Certara's price analysis, check to measure Certara's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Certara is operating at the current time. Most of Certara's value examination focuses on studying past and present price action to predict the probability of Certara's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Certara's price. Additionally, you may evaluate how the addition of Certara to your portfolios can decrease your overall portfolio volatility.